MEDNAX, Inc. (MD) Tops Q2 EPS by 1c

MEDNAX, Inc. (NYSE: MD) reported Q2 EPS of $0.79, $0.01 better than the analyst estimate of $0.78. Revenue for the quarter came in at $595.54 million versus the consensus estimate of $603 million.

MEDNAX, Inc. sees FY2014 EPS of $0.82-$0.86, versus the consensus of $0.86.

For earnings history and earnings-related data on MEDNAX, Inc. (MD) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance